BOLT vs SMFG
Bolt Biotherapeutics (BOLT) versus SMFG (SMFG) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
SMFG (SMFG) common stock.
Latest reported BOLT revenue for 2026-06-30 was $31.0K. Net income was -$15.0M. Revenue was up 19.2% from 2026-03-31 to 2026-06-30. BOLT currently screens at market cap $11.3M.
SMFG does not have a complete income-statement cache yet.
BOLT currently screens at market cap $11.3M. SMFG currently screens at market cap $0.
Not investment advice. Open the BOLT and SMFG stock pages for the full models.
Not investment advice.